Safety of Intravenously Applied Mistletoe Extract – Results from a Phase I Dose Escalation Study in Patients with Advanced Cancer
BMC Complementary and Alternative Medicine（2017）
摘要
Mistletoe extracts have anti-tumor properties and are approved for subcutaneous use in cancer patients. Data on Intravenous application are limited.
更多查看译文
关键词
Viscum album,Intravenous,Cancer,Clinical trial,MTD,Side effects
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要